期刊文献+

提高CpG ODN免疫效价方法的研究进展

下载PDF
导出
摘要 1995年Krieg等〔1〕研究发现CpG二寡聚核苷酸(ODN)是病原体DNA免疫刺激活性的基础结构并等将这类含有非甲基化CpG的特定结构称为CpG基序,也有学者称其为免疫刺激序列。其中,组成CpG ODN胞嘧啶的第五位碳原子必须是非甲基化的,正是因为这种结构,使CpG ODN具有免疫刺激活性作用,换言之,这也是CpG ODN免疫刺激活性的核心结构。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2014年第3期830-833,共4页 Chinese Journal of Gerontology
基金 国家自然科学基金资助课题(No.81371153) 吉林省科技厅科研基金资助课题(No.201115105)
  • 相关文献

参考文献8

  • 1Jie Chen,Chengyu Deng,Qingmin Shi,Jun Jiang,Yongbo Zhang,Wei Shan,Weimin Sun.CpG oligodeoxynucleotide induces bone marrow precursor cells into myeloid-derivedsuppressor cells[J]. Molecular Medicine Reports . 2013 (4)
  • 2KeiYasuda,MarkRutz,BeatrixSchlatter,JochenMetzger,Peter B.Luppa,FrankSchmitz,TobiasHaas,AntjeHeit,StefanBauer,HermannWagner.CpG motif‐independent activation of TLR9 upon endosomal translocation of “natural” phosphodiester DNA[J]. Eur. J. Immunol. . 2006 (2)
  • 3Tara L. Roberts,Jasmyn A. Dunn,Matthew J. Sweet,David A. Hume,Katryn J. Stacey.The immunostimulatory activity of phosphorothioate CpG oligonucleotides is affected by distal sequence changes[J]. Molecular Immunology . 2011 (8)
  • 4Song Chen,Huijie Zhang,Shanmugavel Chinnathambi,Nobutaka Hanagata.Synthesis of novel chitosan–silica/CpG oligodeoxynucleotide nanohybrids with enhanced delivery efficiency[J]. Materials Science & Engineering C . 2013 (6)
  • 5Dennis M. Klinman,Sven Klaschik,Takashi Sato,Debbie Tross.CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases[J]. Advanced Drug Delivery Reviews . 2009 (3)
  • 6Makiya Nishikawa,Yumiko Mizuno,Kohta Mohri,Nao Matsuoka,Sakulrat Rattanakiat,Yuki Takahashi,Hisakage Funabashi,Dan Luo,Yoshinobu Takakura.Biodegradable CpG DNA hydrogels for sustained delivery of doxorubicin and immunostimulatory signals in tumor-bearing mice[J]. Biomaterials . 2010 (2)
  • 7Sakulrat Rattanakiat,Makiya Nishikawa,Hisakage Funabashi,Dan Luo,Yoshinobu Takakura.The assembly of a short linear natural cytosine-phosphate-guanine DNA into dendritic structures and its effect on immunostimulatory activity[J]. Biomaterials . 2009 (29)
  • 8Udo Holtick,Max E Scheulen,Michael S von Bergwelt-Baildon,Martin R Weihrauch.Toll-like receptor 9 agonists as cancer therapeutics[J]. Expert Opinion on Investigational Drugs . 2011 (3)

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部